{
  "abstract": "Canada has become only the second country in the world to approve a generic form of the blockbuster drug Ozempic (semaglutide), made possible after its manufacturer, Novo Nordisk, did not pay a $C250 annual fee.",
  "authors": [
    {
      "affiliations": [
        "St Stephen, New Brunswick"
      ],
      "name": "Brian Owens"
    }
  ],
  "title": "Ozempic generic approved in Canada after Novo Nordisk doesn't pay $250 government fee",
  "uid": "6da2caae-c45b-5901-ba7a-894a6ec1ed69"
}